uniQure to Advance AMT-061 Gene Therapy for Hemophilia B to Clinical Trial in 2018 – Hemophilia News Today
Hemophilia News Today |
uniQure to Advance AMT-061 Gene Therapy for Hemophilia B to Clinical Trial in 2018
Hemophilia News Today uniQure plans to advance its investigational gene therapy AMT-061 into a pivotal study in 2018 for patients with severe and moderately severe hemophilia B. Gene therapies are being develop to treat diseases caused by genetic mutations. It involves … |
